A “game changer” study has concluded many prostate cancer patients need half as much radiation treatment as currently given. Ontario hospitals are already starting to change treatment to four weeks from the standard eight because of the study led by Hamilton’s Juravinski and Toronto’s Princess Margaret cancer centres. Read the article here.
Hamilton study a “game changer” for prostate cancer treatment Read More »
This New England Journal of Medicine article gives the results of a randomized trial of 3 possible prostate cancer treatments. It is rather long and academic, but shows similar results for the 3 options. Read the article here.
A new form of highly personalised treatment for prostate cancer is showing promise in preserving potency. The new technique, termed “vessel sparing radiation”, preserved erectile function in 80 per cent of men at the five-year follow-up while maintaining excellent cure rates. Read the article.
Technical improvements preserve potency after treatment for prostate cancer Read More »
A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) to treat prostate cancer offers a higher cure rate than more traditional approaches. The study – the first trial to publish five-year results from SBRT treatment for prostate cancer – found a 98.6 percent cure rate with SBRT, a noninvasive form of radiation treatment that involves high-dose radiation beams entering the body through various angles and intersecting at the desired target. It is a state-of-the-art technology that allows for a concentrated dose to reach the tumor while limiting the radiation dose to surrounding healthy tissue. Read the article.
New technology has enabled doctors to administer higher doses of radiation to prostate cancer patients with fewer side effects. However, a new study shows that escalating the dose may not actually help a patient in the long term, at least not patients with localized prostate cancer. Read the article.
For prostate cancer, more radiation may not improve survival Read More »
Researchers have found a possible association between radiotherapy for the treatment of prostate cancer and an increased risk of developing secondary cancers of the bladder, colorectal tract, and rectum. Read the article.
The optimal treatment of clinically localized prostate cancer is controversial. Most studies focus on biochemical (PSA) failure when comparing radical prostatectomy (RP) with radiation therapy (RT), but this endpoint has not been validated as predictive of overall survival (OS) or cause-specific survival (CSS) The available literature was analyzed to determine whether reliable conclusions could be made concerning the effectiveness of RP compared with RT with or without androgen deprivation therapy (ADT). Reliable evidence that RP provides a superior CSS to RT with ADT is lacking. The most reliable studies suggest that the differences in 10-year CSS between RP and RT
Researchers at the Perelman School of Medicine at the University of Pennsylvania have found that men undergoing radiation treatment for prostate cancer can stabilize and even decrease the side effects of the treatment with yoga. Read the article.
Yoga Can Reduce Side Effects Of Radiation Treatment In Prostate Cancer Patients Read More »
This somewhat general article discusses various radiation options for prostate cancer, including: High Dose Rate brachytherapy – a form of focal therapy High fraction external beam radiotherapy Read the article.
Advances in Radiation Treatment for Prostate Cancer Read More »
November 2014 Scotiabank Awareness Night Radiation Therapy: Where we 2014 and where we are going Dr. Padraig Warde, MB, ChB, BAO, FRCPC Princess Margaret Cancer Centre Professor, Dept of Radiation Oncology, U of Toronto Staff Radiation Oncologist, Princess Margaret Hospital/University Health Network Provincial Head, Radiation Treatment Program Cancer Care Ontario CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 47:12 minutes
Video: Dr. Padraig Warde, “Radiation Therapy: Where we are 2014 and where we are going” Read More »